https://www.selleckchem.com/pr....oducts/ap-3-a4-enobl
of imaging procedures in the evaluation of disease activity and treatment response. A close disease monitoring with imaging techniques should be taken into account in GCA patients during TCZ treatment. Acute kidney injury (AKI) affects from 20% to 50% of cirrhotic patients, and the one-month mortality rate is 60%. The main cause of AKI is bacterial infection, which worsens circulatory dysfunction through the release of HMGB1 and IL-6. To evaluate HMGB1 and IL-6 as biomarkers of morbidity/mortality. Prospective, observational st
Like
Comment
Share
